Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors

BACKGROUND: Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) assessed the cardiovascular (CV) safety of sitagliptin versus placebo on CV outcomes in patients with type 2 diabetes and CV disease and found sitagliptin noninferior to placebo. Subsequently, based on feedback from FDA, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Scirica, Benjamin M., Im, KyungAh, Murphy, Sabina A., Kuder, Julia F., Rodriguez, Dolly A., Lopes, Renato D., Green, Jennifer B., Ruff, Christian T., Sabatine, Marc S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286326/
https://www.ncbi.nlm.nih.gov/pubmed/35715946
http://dx.doi.org/10.1002/clc.23844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286326/
https://www.ncbi.nlm.nih.gov/pubmed/35715946
http://dx.doi.org/10.1002/clc.23844

Ejemplares similares